Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort study

Autor(es):Mostrar menos -

Reis, Bruna Z. ^[1] ; Fernandes, Alan L. ^[1] ; Sales, Lucas P. ^[1] ; Santos, Mayara D. ^[1] ; Dos Santos, Caroline C. ^[1] ; Pinto, Ana J. ^[2] ; Goessler, Karla F. ^[2] ; Franco, Andre S. ^[1] ; Duran, Camila S. C. ^[1] ; Silva, Carla B. R. ^[1] ; Macedo, Marina B. ^[1] ; Dalmolin, Henrique H. H. ^[1] ; Baggio, Janaina ^[1] ; Balbi, Guilherme G. M. ^[1] ; Antonangelo, Leila ^[3] ; Caparbo, Valeria F. ^[1] ; Gualano, Bruno ^{[4, 2]} ; Murai, Igor H. ^[1] ; Pereira, Rosa M. R. ^[1]

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo HCFMUSP, Fac Med Univ Sao Paulo, Rheumatol Div, Hosp Clin, Fac Med, Sao Paulo, SP - Brazil

^[2] Univ Sao Paulo, Appl Physiol & Nutr Res Grp, Fac Med, Sao Paulo - Brazil

^[3] Univ Sao Paulo, Hosp Clin HCFMUSP, Clin Pathol Div, Fac Med, Sao Paulo - Brazil

^[4] Univ Sao Paulo, Food Res Ctr, Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: AMERICAN JOURNAL OF CLINICAL NUTRITION; v. 114, n. 2, p. 598-604, AUG 2021.
• Citações Web of Science: 0

Resumo

Background: Vitamin D acts as a mediator in the immune system regulating antiviral mechanisms and inflammatory processes. Vitamin D insufficiency has been suggested as a potential risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, although its impact on the prognosis of hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear. Objective: This multicenter prospective cohort study was designed to investigate whether serum 25-hydroxyvitamin D {[}25(OH)D] concentration is associated with hospital length of stay and prognosis in hospitalized patients with COVID-19. Methods: Patients with moderate to severe COVID-19 (n = 220) were recruited from 2 hospitals in Sao Paulo, Brazil. Serum 25(OH)D concentrations were categorized as follows: <10 ng/mL, 10 to <20 ng/mL, 20 to <30 ng/mL, and >= 30 ng/mL, and <10 ng/mL and >= 10 ng/mL. The primary outcome was hospital length of stay and the secondary outcomes were the rate of patients who required invasive mechanical ventilation and mortality. Results: There were no significant differences in hospital length of stay when the 4 25(OH)D categories were compared (P = 0.120). Patients exhibiting 25(OH)D<10 ng/mL showed a trend (P = 0.057) for longer hospital length of stay compared with those with 25(OH)D >= 10 ng/mL {[}9.0 d (95% CI: 6.4, 11.6 d) vs. 7.0 d (95% CI: 6.6, 7.4 d)]. The multivariable Cox proportional hazard models showed no significant associations between 25(OH)D and primary or secondary outcomes. Conclusions: Among hospitalized patients with moderate to severe COVID-19, those with severe 25(OH)D deficiency (<10 ng/mL) exhibited a trend for longer hospital length of stay compared with patients with higher 25(OH)D concentrations. This association was not significant in the multivariable Cox regression model. Prospective studies should test whether correcting severe 25(OH)D deficiency could improve the prognosis of patients with COVID-19. (AU)

• Processo FAPESP: 17/13552-2 - Reduzindo tempo sedentário em populações clínicas: o estudo take a stand for health
• Beneficiário: Bruno Gualano
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 15/26937-4 - Estudos sobre (in)atividade física em pacientes com artrite reumatóide: caracterização, associações com a doença e efeitos da interrupção do tempo sedentário
• Beneficiário: Ana Jéssica Pinto
• Modalidade de apoio: Bolsas no Brasil - Doutorado Direto
• Processo FAPESP: 19/18039-7 - Reduzindo tempo sedentário em pacientes bariátricos: um estudo controlado e randomizado
• Beneficiário: Karla Fabiana Goessler
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 16/00006-7 - Avaliação de parâmetros do metabolismo ósseo por HR-pQCT e histomorfometria em pacientes com artrite reumatoide e com artrite idiopática juvenil: associação com variáveis clínicas e genéticas
• Beneficiário: Eduardo Ferreira Borba Neto
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 20/05752-4 - Suplementação com vitamina D em pacientes com COVID-19: ensaio clínico, randomizado, duplo-cego e controlado por placebo
• Beneficiário: Rosa Maria Rodrigues Pereira
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 19/24782-4 - Comparação dos mecanismos de perda óssea em pacientes submetidos à derivação gástrica em Y de Roux ou gastrectomia vertical
• Beneficiário: Igor Hisashi Murai
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 20/11102-2 - Suplementação com vitamina D em pacientes com COVID-19: ensaio clínico, randomizado, duplo-cego e controlado por placebo
• Beneficiário: Alan Lins Fernandes
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado